Autor Dreyer, Carolin
-
2019 | Zeitschriftenartikel |
Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity
Ott, M.; Avendaño-Guzmán, E.; Ullrich, E.; Dreyer, C.; Strauss, J.; Harden, M. & Schön, M. u.a. (2019)
Journal of Neuroinflammation, 16(1) art. 49. DOI: https://doi.org/10.1186/s12974-019-1437-0
Details DOI